Table 2. Estimated potential number of mpox cases in South Africa among MSMLAHIV, MSMLHIV and in total under four scenarios with corresponding parameter assumptions.
| Scenario: | Central | Sensitivity analyses | ||
| OR of LHIV among mpox cases vs all MSM: | 9.2 (8.0–10.6) | 9.2 (8.0–10.6) | 1 | 1 |
| Definition of AHIV: | CD4<200/mm3 | CD4<100/mm3 | CD4<200/mm3 | CD4<100/mm3 |
| Observed | 3 | 3 | 3 | 3 |
| Assumed | 15.0%(10.2%–20.6%) | 27.1%(18.1%–36.8%) | 15.0%(10.2%–20.6%) | 27.1%(18.1%–36.8%) |
| Estimated | 21 (15–29) | 11 (8–17) | 21 (15–29) | 11 (8–17) |
| Observed | 15 | 15 | 15 | 15 |
| Assumed | 6.6% | 3.3% | 6.6% | 3.3% |
| Estimated | 313(227–444) | 458(455–503) | 313(227–444) | 458(455–503) |
| Assumed | 79.1%(75.0%–82.9%) | 79.1%(75.0%–82.9%) | 29.4%(25.5%–33.5%) | 29.4%(25.5%–33.5%) |
| Estimated | 395(287–562) | 579(549–640) | 1068(750–1543) | 1565(1361–1832) |
| Estimated | 0.78%(0.53%–1.05%) | 0.52%(0.47%–0.55%) | 0.29%(0.19%–0.40%) | 0.19%(0.16%–0.22%) |
| Estimated cases detected | 5.7%(3.9%–7.7%) | 3.8%(3.4%–4.0%) | 2.1%(1.4%–2.9%) | 1.4%(1.2%–1.6%) |
Results are presented as mean (95% CI) where applicable.
AHIVadvanced HIVLHIVliving with HIVMSMmen-who-have-sex-with-menMSMLAHIVMSM living with advanced HIVMSMLHIVMSM living with HIV